I was long SQNM and have been years because I think NIPT is a booming business and SQNM was the first runner, in a strong position in term of IP and technology. This turned out my worst investment because SQNM management was incompetent to grow the company, and wasted us investors money and a few years of time. When I say management, I meant from previous HH to current WW.
If I was a fund manager of a major holder, I would do one or more the following things to boost shareholders value.
1, Oust WW and bring in an external CEO. Don't look for a CEO from current management or BOD --- they are all corrupted and incompetent. Years of failures and shameless bonuses proved this. Any major holder can initiate a proxy fight and ask to add new BOD members and/or remove current ones.
2, Remove the poison pill. We need hostile takeover happening. The poison pill kept hostile takeout from happening.
3, Seek buyout suitor.
4, Sell NIPT service business, but hold IP and keep the part of patent pooling with ILMN. SQNM didn't make profit from past and current NIPT service, and it's quite obvious they could not reduce its cost and/or improve its margin. Sell this part and make it just another licensee who pays loyalties back to SQNM. Then SQNM collects and uses on loyalties and fees, and focuses on R&D such as liquid biopsy.
I hope someone can convey this some of major holding funds or institutions, or to activists who see and believe there are values covered in this stock.